Comutations in DNA Damage Response Pathways Serve as Potential Biomarkers for Immune Checkpoint Blockade-Reference-Cited by-同舟云学术

Comutations in DNA Damage Response Pathways Serve as Potential Biomarkers for Immune Checkpoint Blockade

Published:2018-08-31 Issue:22 Volume:78 Page:6486-6496
ISSN:0008-5472
Container-title:Cancer Research
language:en
Short-container-title:Cancer Res

Author:

Wang Zhijie,Zhao Jing,Wang Guoqiang,Zhang Fan,Zhang Zemin,Zhang Fan,Zhang Yuzi,Dong Hua,Zhao Xiaochen,Duan Jianchun,Bai Hua,Tian Yanhua,Wan Rui,Han Miao,Cao Yan,Xiong Lei,Liu Li,Wang Shuhang,Cai Shangli,Mok Tony S.K.,Wang Jie

Funder

National Natural Science Foundation of China

National Key R&D Program of China

National High Technology Research and Development

CAMS

China National Natural Sciences Foundation

Beijing Natural Science Foundation

Beijing Novel Program

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 179 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DNA repair-dependent immunogenic liabilities in colorectal cancer: opportunities from errors;British Journal of Cancer;2024-09-13

2. Antithetical impacts of deleterious LRP1B mutations in non-squamous and squamous NSCLCs on predicting benefits from immune checkpoint inhibitor alone or with chemotherapy over chemotherapy alone: retrospective analyses of the POPLAR/OAK and CHOICE-01 trials;Science China Life Sciences;2024-09-12

3. PTPRT loss enhances anti–PD-1 therapy efficacy by regulation of STING pathway in non–small cell lung cancer;Science Translational Medicine;2024-09-04

4. Leveraging diverse cellular stress patterns for predicting clinical outcomes and therapeutic responses in patients with multiple myeloma;Journal of Cellular and Molecular Medicine;2024-09

5. DNA damage response-related signatures characterize the immune landscape and predict the prognosis of HCC via integrating single-cell and bulk RNA-sequencing;International Immunopharmacology;2024-08